BMJ  2007;334:1020 (19 May), doi:10.1136/bmj.39212.713160.3A

Letters

Drug money for patient groups

Cancerbackup sets record straight

The first 100% of the full text of this article appears below.

Mintzes says that Cancerbackup does not list the possible side effects of trastuzumab or say where its funding comes from—this is not the case.1

Cancerbackup provides up to date and accurate information about treatment including all possible side effects, both on our website (www.cancerbackup.org.uk) and in our factsheets.

We provide a full list on our website and now in our press releases of all funders.

We are advised by an independent clinical advisory board. Pharmaceutical companies have no influence on any decision we take.

Joanne Rule, chief executive

Cancerbackup, London EC2A 3JR

rgarnett@cancerbackup.org.uk

Competing interests: None declared.

  1. Mintzes B. Should patient groups accept money from drug companies? No. BMJ 2007;334:935. (5 May.)[Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Should patient groups accept money from drug companies? No
Barbara Mintzes
BMJ 2007 334: 935. [Extract] [Full Text] [PDF]

Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview